Dayane Gabriele

Learn More
According to the current guidelines, computed tomography (CT) and bone scintigraphy (BS) are optional in intermediate-risk and recommended in high-risk prostate cancer (PCa). We wonder whether it is time for these examinations to be dismissed, evaluating their staging accuracy in a large cohort of radical prostatectomy (RP) patients. To evaluate the ability(More)
Prostate tumor (PT) normally has an indolent course during the first 10 to 15 years. Tumor progression and its clinical management, in the elderly patients, is therefore becoming a social problem, and the feasibility of non-therapeutic approaches, such as the Wait & Watch (W&W) one, requires a better understanding of the tumor natural history. Our(More)
In the general framework of the European ICT Project CHIC, focused on the building of a common repository for data and models in the field of human cancer, we are collecting clinical, serological and pathological data about prostate cancer for prognostic and growth modeling purposes. Two ongoing retrospective observational studies, named EUREKA-1 and(More)
  • 1